ArticleAllergy and asthma proceedings2022
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management.
Article in Allergy and asthma proceedings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 16 citations in OpenAlex.
- Perspectives on allergic diseases: From asthma to food allergy - A continuing challenge for the Allergist-Immunologist.Allergy and asthma proceedings · 2024Article
- Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.Allergy and asthma proceedings · 2024Article
- A Cross-Sectional Study of Quality of Life in Patients Enrolled in the Romanian Hereditary Angioedema Registry.Cureus · 2024Article
- Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.Allergy and asthma proceedings · 2024Article
- Patient-physician interactions in hereditary angioedema-Key learnings from the coronavirus disease 2019 pandemic.Clinical and translational allergy · 2023Review
- Internet of Medical Things and Healthcare 4.0: Trends, Requirements, Challenges, and Research Directions.Sensors (Basel, Switzerland) · 2023Review
- The complexities of allergic diseases continue to challenge the allergist-immunologist.Allergy and asthma proceedings · 2023Article
- Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course.Allergy and asthma proceedings · 2022Article
- A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.Allergy and asthma proceedings · 2022Article
- Asthma biomarkers and COVID-19 continue to dominate current medical issues.Allergy and asthma proceedings · 2022Article
- Article
- Eosinophilic esophagitis: from discovery to effective treatment.Allergy and asthma proceedings · 2022Article
- Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.Allergy and asthma proceedings · 2022Article
- Evaluation and management of adverse reactions to the COVID-2019 vaccines.Allergy and asthma proceedings · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.